Impact of Apolipoprotein E ε4 in Alzheimer’s Disease: A Meta-Analysis of Voxel-Based Morphometry Studies
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Purpose Alzheimer’s disease (AD) is the most-prevalent form of dementia and imposes substantial burdens at the personal and societal levels. The apolipoprotein E (APOE) ε4 allele is a genetic factor known to increase AD risk and exacerbate brain atrophy and its symptoms. We aimed to provide a comprehensive review of the impacts of APOE ε4 on brain atrophy in AD as well as in mild cognitive impairment (MCI) as a transitional stage of AD. Methods We performed a coordinate-based meta-analysis of voxel-based morphometry studies to compare gray-matter atrophy patterns between carriers and noncarriers of APOE ε4. We obtained coordinate-based structural magnetic resonance imaging data from 1,135 individuals who met our inclusion criteria among 12 studies reported in PubMed and Google Scholar. Results We found that atrophy of the hippocampus and parahippocampus was significantly greater in APOE ε4 carriers than in noncarriers, especially among those with AD and MCI, while there was no significant atrophy in these regions in healthy controls who were also carriers. Conclusions The present meta-analysis has highlighted the significant link between the APOE ε4 allele and hippocampal atrophy in both AD and MCI, which emphasizes the critical influence of the allele on neurodegeneration, especially in the hippocampus. These findings improve the understanding of AD pathology, potentially facilitating progress in early detection, targeted interventions, and personalized care strategies for individuals at risk of AD who carry the APOE ε4 allele.
Abstract
Background and Purpose Alzheimer’s disease (AD) is the most-prevalent form of dementia and imposes substantial burdens at the personal and societal levels. The apolipoprotein E (APOE) ε4 allele is a genetic factor known to increase AD risk and exacerbate brain atrophy and its symptoms. We aimed to provide a comprehensive review of the impacts of APOE ε4 on brain atrophy in AD as well as in mild cognitive impairment (MCI) as a transitional stage of AD. Methods We performed a coordinate-based meta-analysis of voxel-based morphometry studies to compare gray-matter atrophy patterns between carriers and noncarriers of APOE ε4. We obtained coordinate-based structural magnetic resonance imaging data from 1,135 individuals who met our inclusion criteria among 12 studies reported in PubMed and Google Scholar. Results We found that atrophy of the hippocampus and parahippocampus was significantly greater in APOE ε4 carriers than in noncarriers, especially among those with AD and MCI, while there was no significant atrophy in these regions in healthy controls who were also carriers. Conclusions The present meta-analysis has highlighted the significant link between the APOE ε4 allele and hippocampal atrophy in both AD and MCI, which emphasizes the critical influence of the allele on neurodegeneration, especially in the hippocampus. These findings improve the understanding of AD pathology, potentially facilitating progress in early detection, targeted interventions, and personalized care strategies for individuals at risk of AD who carry the APOE ε4 allele.
참고문헌 (67)
- Lanctôt KL, "Burden of illness in people with Alzheimer’s disease : a systematic review of epidemiology, comorbidities and mortality", J Prev Alzheimers Dis, 11, pp.97~107 (2024)
- "2022 Alzheimer’s disease facts and figures", Alzheimers Dement, 18, pp.700~789 (2022)
- Pini L, "Brain atrophy in Alzheimer’s disease and aging", Ageing Res Rev, 30, pp.25~48 (2016)
- Jahn H, "Memory loss in Alzheimer’s disease", Dialogues Clin Neurosci, 15, pp.445~454 (2013)
- Corey-Bloom J, "The ABC of Alzheimer’s disease : cognitive changes and their management in Alzheimer’s disease and related dementias", Int Psychogeriatr, 14(Suppl 1), pp.51~75 (2002)
- Eid A, "Gene-environment interactions in Alzheimer’s disease : a potential path to precision medicine", Pharmacol Ther, 199, pp.173~187 (2019)
- Liu CC, "Apolipoprotein E and Alzheimer disease : risk, mechanisms and therapy", Nat Rev Neurol, 9, pp.106~118 (2013)
- Corder EH, "Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families", Science, 261, pp.921~923 (1993)
- Farrer LA, "Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease : a meta-analysis", JAMA, 278, pp.1349~1356 (1997)
- Corder EH, "Attenuation of apolipoprotein E epsilon4 allele gene dose in late age", Lancet, 347, pp.542~ (1996)
- Frisoni GB, "Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer’s disease", Ann Neurol, 37, pp.596~604 (1995)
- Cosentino FI, "The APOE epsilon4 allele increases the risk of impaired spatial working memory in obstructive sleep apnea", Sleep Med, 9, pp.831~839 (2008)
- Li K, "Correlation between brain structure atrophy and plasma amyloid-β and phosphorylated Tau in patients with Alzheimer’s disease and amnestic mild cognitive impairment explored by surface-based morphometry", Front Aging Neurosci, 14, pp.816043~ (2022)
- Goedert M, "Neurofibrillary tangles and betaamyloid deposits in Alzheimer’s disease", Curr Opin Neurobiol, 1, pp.441~447 (1991)
- Rao YL, "Hippocampus and its involvement in Alzheimer’s disease : a review", 3 Biotech, 12, pp.55~ (2022)
- Chu LW, "Alzheimer’s disease : early diagnosis and treatment", Hong Kong Med J, 18, pp.228~237 (2012)
- Josephs KA, "Rates of hippocampal atrophy and presence of postmortem TDP-43 in patients with Alzheimer’s disease : a longitudinal retrospective study", Lancet Neurol, 16, pp.917~924 (2017)
- Benson GS, "Don’t forget about tau : the effects of ApoE4 genotype on Alzheimer’s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment-data from the dementia competence network", J Neural Transm(Vienna), 129, pp.477~486 (2022)
- Moreno-Grau S, "Genome-wide significant risk factors on chromosome 19 and the APOE locus", Oncotarget, 9, pp.24590~24600 (2018)
- Mahley RW, "Apolipoprotein E : cholesterol transport protein with expanding role in cell biology", Science, 240, pp.622~630 (1988)
- Husain MA, "APOE and Alzheimer’s disease : from lipid transport to physiopathology and therapeutics", Front Neurosci, 15, pp.630502~ (2021)
- Phillips MC, "Apolipoprotein E isoforms and lipoprotein metabolism", IUBMB Life, 66, pp.616~623 (2014)
- Di Battista AM, "Alzheimer’s disease genetic risk factor APOE-ε4 also affects normal brain function", Curr Alzheimer Res, 13, pp.1200~1207 (2016)
- Caselli RJ, "Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect", N Engl J Med, 361, pp.255~263 (2009)
- Villemagne VL, "Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease : a prospective cohort study", Lancet Neurol, 12, pp.357~367 (2013)
- Nelson PT, "APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature", J Neuropathol Exp Neurol, 72, pp.708~715 (2013)
- Tai LM, "Levels of soluble apolipoprotein E", amyloid-β(Aβ)complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples, 2013, pp.288, 5914~5926
- Manning EN, "APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD", PLoS One, 9, pp.e97608~ (2014)
- Wolk DA, "Apolipoprotein E(APOE)genotype has dissociable effects on memory and attentional-executive network function in Alzheimer’s disease", Proc Natl Acad Sci U S A, 107, pp.10256~10261 (2010)
- Dona O, "Comprehensive review on magnetic resonance imaging in Alzheimer’s disease", Crit Rev Biomed Eng, 44, pp.213~225 (2016)
- Ashburner J, "Voxel-based morphometry--the methods", Neuroimage, 11(6 Pt 1), pp.805~821 (2000)
- Eickhoff SB, "Coordinate-based activation likelihood estimation meta-analysis of neuroimaging data : a random-effects approach based on empirical estimates of spatial uncertainty", Hum Brain Mapp, 30, pp.2907~2926 (2009)
- Li J, "A meta-analysis of voxel-based morphometry studies of white matter volume alterations in Alzheimer’s disease", Neurosci Biobehav Rev, 36, pp.757~763 (2012)
- Ferreira LK, "Neurostructural predictors of Alzheimer’s disease : a meta-analysis of VBM studies", Neurobiol Aging, 32, pp.1733~1741 (2011)
- Wang WY, "Voxel-based meta-analysis of grey matter changes in Alzheimer’s disease", Transl Neurodegener, 4, pp.6~ (2015)
- Page MJ, "The PRISMA 2020 statement : an updated guideline for reporting systematic reviews", BMJ, 372, pp.n71~ (2021)
- Laird AR, "Comparison of the disparity between Talairach and MNI coordinates in functional neuroimaging data : validation of the Lancaster transform", Neuroimage, 51, pp.677~683 (2010)
- Yarkoni T, "Largescale automated synthesis of human functional neuroimaging data", Nat Methods, 8, pp.665~670 (2011)
- Aerts H, "Brain networks under attack : robustness properties and the impact of lesions", Brain, 139(Pt 12), pp.3063~3083 (2016)
- Lancaster TM, "Microglia – mediated immunity partly contributes to the genetic association between Alzheimer’s disease and hippocampal volume", Brain Behav Immun, 79, pp.267~273 (2019)
- Chauhan G, "Association of Alzheimer’s disease GWAS loci with MRI markers of brain aging", Neurobiol Aging, 36, pp.1765~ (2015)
- Fleisher A, "Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment", Arch Neurol, 62, pp.953~957 (2005)
- Fleisher AS, "Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease", Neurobiol Aging, 34, pp.1~12 (2013)
- Lupton MK, "The effect of increased genetic risk for Alzheimer’s disease on hippocampal and amygdala volume", Neurobiol Aging, 40, pp.68~77 (2016)
- Kerchner GA, "APOE ε4 worsens hippocampal CA1 apical neuropil atrophy and episodic memory", Neurology, 82, pp.691~697 (2014)
- Bird CM, "The hippocampus and memory : insights from spatial processing", Nat Rev Neurosci, 9, pp.182~194 (2008)
- Aminoff EM, "The role of the parahippocampal cortex in cognition", Trends Cogn Sci, 17, pp.379~390 (2013)
- van Strien NM, "The anatomy of memory : an interactive overview of the parahippocampal-hippocampal network", Nat Rev Neurosci, 10, pp.272~282 (2009)
- Aggleton JP, "Time to retire the serial Papez circuit : implications for space, memory, and attention", Neurosci Biobehav Rev, 140, pp.104813~ (2022)
- Forno G, "Going round in circles—the Papez circuit in Alzheimer’s disease", Eur J Neurosci, 54, pp.7668~7687 (2021)
- Buckner RL, "The brain’s default network : anatomy, function, and relevance to disease", Ann N Y Acad Sci, 1124, pp.1~38 (2008)
- Callen DJ, "Beyond the hippocampus : MRI volumetry confirms widespread limbic atrophy in AD", Neurology, 57, pp.1669~1674 (2001)
- Haller S, "APOE*E4 is associated with gray matter loss in the posterior cingulate cortex in healthy elderly controls subsequently developing subtle cognitive decline", AJNR Am J Neuroradiol, 38, pp.1335~1342 (2017)
- Sheline YI, "APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42", J Neurosci, 30, pp.17035~17040 (2010)
- Dickerson BC, "The cortical signature of Alzheimer’s disease : regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals", Cereb Cortex, 19, pp.497~510 (2009)
- Alexander GE, "Gray matter network associated with risk for Alzheimer’s disease in young to middle-aged adults", Neurobiol Aging, 33, pp.2723~2732 (2012)
- Brys M, "Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer’s disease", J Alzheimers Dis, 16, pp.351~362 (2009)
- Chang YT, "Genetic interaction of APOE and FGF1 is associated with memory impairment and hippocampal atrophy in Alzheimer’s disease", Aging Dis, 10, pp.510~519 (2019)
- Forno G, "The APOE4 effect : structural brain differences in Alzheimer’s disease according to the age at symptom onset", Eur J Neurol, 30, pp.597~605 (2023)
- Goltermann J, "Apolipoprotein E homozygous ε4 allele status : a deteriorating effect on visuospatial working memory and global brain structure", Front Neurol, 10, pp.552~ (2019)
- Honea RA, "Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease", Neurology, 74, pp.113~120 (2010)
- Honea RA, "Cardiorespiratory fitness and preserved medial temporal lobe volume in Alzheimer disease", Alzheimer Dis Assoc Disord, 23, pp.188~197 (2009)
- Honea RA, "Impact of APOE on the healthy aging brain : a voxel-based MRI and DTI study", J Alzheimers Dis, 18, pp.553~564 (2009)
- Mosconi L, "Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD", Neurology, 82, pp.752~760 (2014)
- Nao J, "Adverse effects of the apolipoprotein E ε4 allele on episodic memory, task switching and gray matter volume in healthy young adults", Front Hum Neurosci, 11, pp.346~ (2017)
- Novellino F, "Association between hippocampus, thalamus, and caudate in mild cognitive impairment APOEε4 carriers : a structural covariance MRI study", Front Neurol, 10, pp.1303~ (2019)
- You M, "The influence of MTHFR polymorphism on gray matter volume in patients with amnestic mild cognitive impairment", Front Neurosci, 15, pp.778123~ (2021)